Read + Share
Amedeo Smart
Independent Medical Education
Maertens JA, Rahav G, Lee DG, Ponce-de-Leon A, et al. Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial. Lancet 2021;397:499-509.PMID: 33549194
Email
LinkedIn
Facebook
Twitter
Privacy Policy